Theseus Pharmaceuticals, Inc. (THRX)

NASDAQ: THRX · IEX Real-Time Price · USD
8.81
0.06 (0.69%)
Jan 27, 2022 3:58 PM EST - Market open

Balance Sheet (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Cash & Equivalents
8.461.32
Cash & Cash Equivalents
8.461.32
Cash Growth
542.14%-
Other Current Assets
0.110.06
Total Current Assets
8.571.38
Property, Plant & Equipment
00
Other Long-Term Assets
0.040.04
Total Long-Term Assets
0.040.05
Total Assets
8.611.43
Accounts Payable
1.130.29
Other Current Liabilities
0.460.33
Total Current Liabilities
1.60.62
Other Long-Term Liabilities
-3.36
Total Long-Term Liabilities
03.36
Total Liabilities
1.63.98
Common Stock
00.81
Retained Earnings
-34.27-10.22
Shareholders' Equity
-34.27-9.41
Total Liabilities and Equity
-32.68-5.43
Net Cash / Debt
8.461.32
Net Cash / Debt Growth
542.14%-
Net Cash Per Share
11.258.28
Working Capital
6.980.77
Book Value Per Share
-45.57-59.17
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).